Harry B Greenberg
Publications
- Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine. J Infect Dis. 2013; (2): 288-96
- Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med. 2013; (171): 171ra19
- Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens. Biotechnol Bioeng. 2012; (12): 2962-9
- Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution. Proc Natl Acad Sci U S A. 2012; (50): 20667-72
- Rhesus rotavirus trafficking during entry into MA104 cells is restricted to the early endosome compartment. J Virol. 2012; (7): 4009-13
- Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011; (8): 3109-19
- Plasmablast-derived polyclonal antibody response after influenza vaccination. J Immunol Methods. 2011; (1-2): 67-75
- Reconciliation of rotavirus temperature-sensitive mutant collections and assignment of reassortment groups D, J, and K to genome segments. J Virol. 2011; (10): 5048-60
- Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes. J Virol. 2011; (6): 2492-503
- Roles of VP4 and NSP1 in determining the distinctive replication capacities of simian rotavirus RRV and bovine rotavirus UK in the mouse biliary tract. J Virol. 2011; (6): 2686-94
- The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3. J Virol. 2011; (8): 3717-32
- Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes. J Interferon Cytokine Res. 2010; (5): 311-20
- Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin. J Virol. 2010; (9): 4543-55
- Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response. PLoS Pathog. 2010; (6): e1000931
- IRF3 inhibition by rotavirus NSP1 is host cell and virus strain dependent but independent of NSP1 proteasomal degradation. J Virol. 2009; (20): 10322-35
- Rotaviruses: from pathogenesis to vaccination. Gastroenterology. 2009; (6): 1939-51
- VP5* rearranges when rotavirus uncoats. J Virol. 2009; (21): 11372-7
- Variation in antagonism of the interferon response to rotavirus NSP1 results in differential infectivity in mouse embryonic fibroblasts. J Virol. 2009; (14): 6987-94
- Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines. PLoS One. 2008; (7): e2574
- Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One. 2008; (8): e2975
- Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines. J Infect Dis. 2008; (6): 803-11
- Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection. J Virol. 2008; (14): 6812-9
- Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J Virol. 2008; (15): 7578-90
- The influence of CD4+ CD25+ Foxp3+ regulatory T cells on the immune response to rotavirus infection. Vaccine. 2008; (44): 5601-11
- Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol. 2007; (1): 215-28
- Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr Infect Dis J. 2007; (2): 107-15
- Reg-II is an exocrine pancreas injury-response product that is up-regulated by keratin absence or mutation. Mol Biol Cell. 2007; (12): 4969-78
- Rotavirus vaccines: recent developments and future considerations. Nat Rev Microbiol. 2007; (7): 529-39
- Active viremia in rotavirus-infected mice. J Virol. 2006; (13): 6702-5
- Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol. 2006; (23): 11756-66
- Dissecting rotavirus particle-raft interaction with small interfering RNAs: insights into rotavirus transit through the secretory pathway. J Virol. 2006; (8): 3935-46
- Extraintestinal spread and replication of a homologous EC rotavirus strain and a heterologous rhesus rotavirus in BALB/c mice. J Virol. 2006; (11): 5219-32
- Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology. 2006; (2): 352-9
- Immunity and correlates of protection for rotavirus vaccines. Vaccine. 2006; (15): 2718-31
- New viral vaccines. Virology. 2006; (1): 240-9
- Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C. J Infect Dis. 2006; (8): 1068-77
- Quantitative evaluation of rotaviral antigenemia in children with acute rotaviral diarrhea. J Infect Dis. 2006; (5): 588-93
- Redundant role of chemokines CCL25/TECK and CCL28/MEC in IgA+ plasmablast recruitment to the intestinal lamina propria after rotavirus infection. J Immunol. 2006; (10): 5749-59
- Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol. 2006; (21): 10692-9
- Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine. 2006; (31-32): 5817-23
- Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice. J Virol. 2005; (8): 4568-79
- Keratin mutation primes mouse liver to oxidative injury. Hepatology. 2005; (3): 517-25
- Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J Virol. 2005; (17): 11014-21
- Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes. Hum Immunol. 2005; (6): 666-76
- VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. J Immunol. 2005; (6): 3454-60
- Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. J Infect Dis. 2004; (9): 1619-27
- Detection and characterization of virus-specific CD8+ T cells using the tetramer approach. Methods Mol Med. 2004: 89-96
- Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation. J Infect Dis. 2004; (5): 989-97
- Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C. J Med Virol. 2004; (4): 575-85
- Immunization against viral respiratory disease: a review. Pediatr Infect Dis J. 2004; (11 Suppl): S254-61
- Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children. J Virol. 2004; (20): 10967-76
- Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988-1999. J Infect Dis. 2004; (12): 2282-9
- T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest. 2004; (12): 1812-9
- The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection. J Immunol Methods. 2004; (1-2): 91-9
- Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol. 2003; (10): 6055-61
- Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J Infect Dis. 2003; (7): 1075-84
- Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles. J Immunol Methods. 2003; (1-2): 223-37
- Human rotavirus specific T cells: quantification by ELISPOT and expression of homing receptors on CD4+ T cells. Virology. 2003; (2): 671-9
- Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J Immunol. 2003; (9): 4680-8
- Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology. 2003; (3): 610-21
- Keratin 20 helps maintain intermediate filament organization in intestinal epithelia. Mol Biol Cell. 2003; (7): 2959-71
- Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J Hepatol. 2003; (1): 67-75
- Rotavirus infectious particles use lipid rafts during replication for transport to the cell surface in vitro and in vivo. Virology. 2003; (1): 308-21
- Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor alpha4beta7. Virology. 2003; (1): 93-105
- A blood-borne antigen induces rapid T-B cell contact: a potential mechanism for tolerance induction. Immunology. 2002; (4): 420-5
- A prenylation inhibitor prevents production of infectious hepatitis delta virus particles. J Virol. 2002; (20): 10465-72
- CD8+ T-cell response against hepatitis C virus. Viral Immunol. 2002; (1): 121-31
- Correlation of tissue distribution, developmental phenotype, and intestinal homing receptor expression of antigen-specific B cells during the murine anti-rotavirus immune response. J Immunol. 2002; (5): 2173-81
- Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol. 2002; (1): 347-55
- Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults. J Virol. 2002; (10): 4741-9
- Gene expression pattern in Caco-2 cells following rotavirus infection. J Virol. 2002; (9): 4467-82
- Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 2002; (6): 3447-58
- Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest. 2002; (9): 1203-13
- Principles, organization, and operation of a DNA bank for clinical trials: a Department of Veterans Affairs cooperative study. Control Clin Trials. 2002; (3): 222-39
- Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci U S A. 2002; (17): 11411-6
- The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med. 2002; (2): 269-75
- Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest. 2001; (5): 595-601
- CCR7 expression and memory T cell diversity in humans. J Immunol. 2001; (2): 877-84
- Challenges for rotavirus vaccines. Virology. 2001; (2): 153-5
- Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood. Viral Immunol. 2001; (1): 59-69
- Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection. Vaccine. 2001; (23-24): 3285-91
- Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry. J Mol Biol. 2001; (5): 985-92
- Protective intestinal anti-rotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production. J Immunol. 2001; (3): 1894-902
- Protective intestinal antirotavirus B cell immunity is dependent on alph4beta7 integrin expression but does not require IgA antibody production J Immunol. 2001
- Protective intestinal antirotavirus B cell immunity is dependent on alph4beta7 integrin expression but does not require IgA antibody production. J Immunol.. 2001; (166): 1894-192
- Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core. J Virol. 2001; (16): 7339-50
- Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis. 2001; (7): 827-35
- Rotavirus assembly - interaction of surface protein VP7 with middle layer protein VP6. Arch Virol. 2001; (6): 1155-71
- CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity. 2000; (5): 495-503
- Hepatitis C virus and the host: An imbalance induced by immunosuppression? Hepatology. 2000; (2): 433-5
- Immunity to calicivirus infection. J Infect Dis. 2000: S331-5
- Immunity to homologous rotavirus infection in adult mice. Trends Microbiol. 2000; (2): 50-2
- In vivo study of immunity to rotaviruses : selected methods in mice. Methods Mol Med. 2000: 133-45
- Lessons in defense: hepatitis C, a case study. Curr Opin Microbiol. 2000; (4): 363-5
- Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med. 2000; (5): 761-8
- Protective immunity to rotavirus shedding in the absence of interleukin-6: Th1 cells and immunoglobulin A develop normally. J Virol. 2000; (11): 5250-6
- Purified recombinant rotavirus VP7 forms soluble, calcium-dependent trimers. Virology. 2000; (2): 420-8
- Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles. Virology. 2000; (2): 444-53
- Rotavirus entry into tissue culture cells. Methods Mol Med. 2000: 67-77
- Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat Med. 2000; (3): 327-31
- alpha(4)beta(7) independent pathway for CD8(+) T cell-mediated intestinal immunity to rotavirus. J Clin Invest. 2000; (12): 1541-52
- Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate. Gastroenterology. 1999; (6): 1397-407
- Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Virology. 1999; (1): 148-53
- Immunity obtained by gene-gun inoculation of a rotavirus DNA vaccine to the abdominal epidermis or anorectal epithelium. Vaccine. 1999; (23-24): 3171-6
- Immunity to rotavirus infection in mice. J Infect Dis. 1999: S466-9
- Isolation of a human rotavirus strain with a super-short RNA pattern and a new P2 subtype. J Clin Microbiol. 1999; (4): 1213-6
- Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice. J Interferon Cytokine Res. 1999; (6): 655-9
- Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A. 1999; (10): 5692-7
- The epithelial cell response to rotavirus infection. J Immunol. 1999; (8): 4442-52
- Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico. J Clin Microbiol. 1998; (6): 1688-92
- Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without. J Virol. 1998; (6): 5323-7
- Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol. 1998; (11): 3223-9
- Expression of the mucosal homing receptor alpha4beta7 correlates with the ability of CD8+ memory T cells to clear rotavirus infection. J Virol. 1998; (1): 726-30
- Identification of mutations in the rotavirus protein VP4 that alter sialic-acid-dependent infection. J Gen Virol. 1998: 725-9
- Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol. 1998; (7): 5757-61
- Studies of the role for NSP4 in the pathogenesis of homologous murine rotavirus diarrhea. J Infect Dis. 1998; (2): 455-8
- The immunology of rotavirus infection in the mouse. Adv Virus Res. 1998: 203-35
- The memory B cell subset responsible for the secretory IgA response and protective humoral immunity to rotavirus expresses the intestinal homing receptor, alpha4beta7. J Immunol. 1998; (8): 4227-35
- Three forms of AU-1 like human rotaviruses differentiated by their overall genomic constellation and by the sequence of their VP8*. Arch Virol. 1998; (2): 263-77
- Use of a prenylation inhibitor as a novel antiviral agent. J Virol. 1998; (11): 9303-6
- CD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice. J Virol. 1997; (5): 4165-70
- Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis. Virology. 1997; (1): 89-96
- Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon. J Virol. 1997; (1): 479-86
- Expression of mucosal homing receptor alpha4beta7 by circulating CD4+ cells with memory for intestinal rotavirus. J Clin Invest. 1997; (5): 1204-8
- Hepatitis G virus infection in hemodialysis patients and the effects of interferon treatment. Am J Gastroenterol. 1997; (11): 1986-91
- Hepatitis G virus: is it a hepatitis virus? West J Med. 1997; (1): 23-33
- Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model. J Infect Dis. 1997; (2): 330-41
- Immune responses to individual rotavirus proteins following heterologous and homologous rotavirus infection in mice. J Infect Dis. 1997; (6): 1317-23
- Immunity to rotavirus in T cell deficient mice. Virology. 1997; (2): 169-79
- Murine model of rotavirus infection. Adv Exp Med Biol. 1997: 233-40
- Protective immunity induced by rotavirus DNA vaccines. Vaccine. 1997; (8): 899-902
- Virus-like particle-induced fusion from without in tissue culture cells: role of outer-layer proteins VP4 and VP7. J Virol. 1997; (6): 4555-63
- Cleavage of rotavirus VP4 in vivo. J Gen Virol. 1996: 391-5
- DNA vaccines against rotavirus infections. Arch Virol Suppl. 1996: 207-15
- Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis. Arch Virol. 1996; (3-4): 715-26
- Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol. 1996; (1): 487-93
- Hepatitis C virus detection by single-round PCR specific for the terminal 3' noncoding region. J Clin Microbiol. 1996; (10): 2552-8
- Molecular determinants of immunity and pathogenicity of rotavirus infection in the mouse model. J Infect Dis. 1996: S47-50
- Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus. Virology. 1996; (1): 97-110
- Protection against rotavirus infections by DNA vaccination. J Infect Dis. 1996: S93-7
- Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 1996; (5258): 104-7
- Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. J Clin Microbiol. 1996; (7): 1694-700
- Rotavirus immunity in the mouse. Arch Virol Suppl. 1996: 141-52
- Analyses of homologous rotavirus infection in the mouse model. Virology. 1995; (1): 143-53
- Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus. J Gen Virol. 1995: 1981-8
- Expression of the rotavirus SA11 protein VP7 in the simple eukaryote Dictyostelium discoideum. J Virol. 1995; (3): 1747-54
- Heterogeneity of VP4 neutralization epitopes among serotype P1A human rotavirus strains. Clin Diagn Lab Immunol. 1995; (4): 506-8
- Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. Virology. 1995; (1): 148-54
- Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus. Arch Virol. 1995; (11): 1969-78
- Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol. 1995; (12): 7800-6
- Rotavirus-induced fusion from without in tissue culture cells. J Virol. 1995; (9): 5582-91
- A monotype of human rotavirus serotype 1 involved in a diarrhea outbreak in a pediatric ward. Isr J Med Sci. 1994; (3): 240-2
- Analysis of astrovirus serotype 1 RNA, identification of the viral RNA-dependent RNA polymerase motif, and expression of a viral structural protein. J Virol. 1994; (1): 77-83
- Antibody response to hepatitis C virus infection after liver transplantation. Am J Gastroenterol. 1994; (8): 1169-74
- Comparison of VP4 and VP7 of five murine rotavirus strains. Virology. 1994; (2): 250-9
- Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol. 1994; (12): 7766-73
- Comparison of the rotavirus nonstructural protein NSP1 (NS53) from different species by sequence analysis and northern blot hybridization. Virology. 1994; (1): 178-83
- Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol. 1994; (10): 6147-60
- Intracellular manipulation of disulfide bond formation in rotavirus proteins during assembly. J Virol. 1994; (8): 5204-15
- Mapping the subgroup epitopes of rotavirus protein VP6. Virology. 1994; (1): 153-62
- Presentation of neutralizing epitopes by engineered rotavirus VP7's expressed by recombinant vaccinia viruses. Virology. 1994; (1): 391-402
- Rapid and sensitive method for detection of hepatitis C virus RNA by using silica particles. J Clin Microbiol. 1994; (10): 2593-7
- Rotavirus pathology and pathophysiology. Curr Top Microbiol Immunol. 1994: 255-83
- Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology. 1993; (1): 374-9
- Characterization and seroepidemiology of a type 5 astrovirus associated with an outbreak of gastroenteritis in Marin County, California. J Clin Microbiol. 1993; (4): 955-62
- Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system. Hepatology. 1993; (5): 763-71
- Cloning and characterization of human astrovirus immunoreactive epitopes. J Virol. 1993; (3): 1712-5
- Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions. Virology. 1993; (1): 397-404
- Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J Virol. 1993; (1): 464-8
- Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol. 1993; (5): 2448-55
- Rotavirus vaccination--current status. A brief summary. Ann N Y Acad Sci. 1993: 32-5
- Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J Clin Microbiol. 1993; (3): 622-8
- Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol. 1993; (1): 165-9
- The endoplasmic reticulum-associated VP7 of rotavirus is targeted to axons and dendrites in polarized neurons. J Neurocytol. 1993; (8): 616-26
- Astroviruses and caliciviruses: emerging enteric pathogens. Infect Agents Dis. 1992; (2): 71-91
- Calcium chelation induces a conformational change in recombinant herpes simplex virus-1-expressed rotavirus VP7. Virology. 1992; (2): 828-32
- Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay. J Clin Microbiol. 1992; (3): 704-11
- Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol. 1992; (12): 3151-7
- Exclusive asymptomatic neonatal infections by human rotavirus strains having subgroup I specificity and "long" RNA electropherotype. Arch Virol. 1992; (1-4): 239-51
- Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus. J Clin Microbiol. 1992; (6): 1392-7
- Isolation and characterization of a novel reassortant between avian Ty-1 and simian RRV rotaviruses. J Virol. 1992; (11): 6836-9
- Liposome-mediated transfection of intact viral particles reveals that plasma membrane penetration determines permissivity of tissue culture cells to rotavirus. J Clin Invest. 1992; (6): 2313-20
- Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse. J Clin Invest. 1992; (6): 1741-5
- Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins. Virology. 1992; (1): 18-32
- Strategies for the identification of icosahedral virus receptors. J Clin Invest. 1992; (1): 3-9
- Antibodies to hepatitis C virus in low-risk blood donors: implications for counseling positive donors. Gastroenterology. 1991; (6): 1724-7
- Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol. 1991; (5): 2211-9
- Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology. 1991; (5): 763-7
- Identification and partial characterization of a rhesus rotavirus binding glycoprotein on murine enterocytes. Virology. 1991; (2): 602-10
- Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice. J Virol. 1991; (11): 5928-32
- Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells. J Virol. 1991; (8): 4190-7
- The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology. 1991; (2): 553-63
- The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest. 1991; (4): 1456-61
- Viral gastroenteritis. N Engl J Med. 1991; (4): 252-64
- DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites. Proc Natl Acad Sci U S A. 1990; (2): 518-22
- Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol. 1990; (6): 1114-9
- Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks. Virology. 1990; (2): 546-52
- Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus. J Virol. 1990; (1): 361-8
- Foodborne Snow Mountain agent gastroenteritis with secondary person-to-person spread in a retirement community. Am J Epidemiol. 1990; (4): 702-10
- Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol. 1990; (4): 1698-703
- Lack of cosegregation of the subgroup II antigens on genes 2 and 6 in porcine rotaviruses. J Virol. 1990; (1): 411-3
- Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis. 1990; (1): 18-21
- NS35 and not vp7 is the soluble rotavirus protein which binds to target cells. J Virol. 1990; (1): 322-30
- Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J Virol. 1990; (9): 4375-82
- Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol. 1990; (3): 504-7
- Sequence analysis of gene 11 equivalents from "short" and "super short" strains of rotavirus. J Virol. 1990; (1): 120-4
- Serotype variation of human group A rotaviruses in two regions of the USA. J Infect Dis. 1990; (3): 605-14
- Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol. 1990; (6): 2687-91
- Subgroup classification of porcine group-A rotaviruses, using monoclonal antibodies in an enzyme-linked immunosorbent assay. Am J Vet Res. 1990; (6): 938-44
- Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol. 1990; (6): 2133-44
- Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus. J Virol. 1989; (6): 2445-51
- Molecular determinant of rotavirus neutralization and protection. Adv Virus Res. 1989: 181-214
- Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol. 1989; (4): 780-2
- Prevalence of acute enteric viral pathogens in acquired immunodeficiency syndrome patients with diarrhea. Gastroenterology. 1989; (4): 1031-2
- Rotavirus VP7 neutralization epitopes of serotype 3 strains. Virology. 1989; (2): 503-15
- Rotavirus serotype IV: nucleotide sequence of genomic segment nine of the St Thomas 3 strain. Nucleic Acids Res. 1989; (1): 449
- Rotavirus-specific protein synthesis is not necessary for recognition of infected cells by virus-specific cytotoxic T lymphocytes. J Virol. 1989; (8): 3279-83
- The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol. 1989; (4): 1661-8
- Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology. 1988; (2): 511-7
- Detection of human rotaviruses which do not react with subgroup I- and II-specific monoclonal antibodies. J Clin Microbiol. 1988; (6): 1238-40
- Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol. 1988; (6): 2164-72
- Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol. 1988; (4): 1136-44
- Isolation of a bovine rotavirus with a "super-short" RNA electrophoretic pattern from a calf with diarrhea. J Clin Microbiol. 1988; (10): 2139-43
- Phenotypic mixing during coinfection of cells with two strains of human rotavirus. J Virol. 1988; (11): 4358-61
- Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela. Pediatr Infect Dis J. 1988; (11): 776-80
- Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol. 1988; (5): 1543-9
- Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus. J Virol. 1988; (9): 3509-12
- The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A. 1988; (3): 645-9
- Two forms of VP7 are involved in assembly of SA11 rotavirus in endoplasmic reticulum. J Virol. 1988; (8): 2929-41
- Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis. 1987; (6): 1159-66
- Epitope-specific immune responses to rotavirus vaccination. Gastroenterology. 1987; (5): 941-50
- A foodborne outbreak of Norwalk virus gastroenteritis. Evidence for post-recovery transmission. Am J Epidemiol. 1986; (1): 120-6
- Antigenic mapping of the surface proteins of rhesus rotavirus. Virology. 1986; (2): 434-51
- Cultivation and characterization of three strains of murine rotavirus. J Virol. 1986; (2): 585-90
- Molecular basis of rotavirus virulence: role of gene segment 4. J Virol. 1986; (1): 46-9
- Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol. 1986; (2): 700-3
- Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol. 1986; (2): 491-6
- Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands. J Infect Dis. 1985; (1): 99-105
- Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol. 1985; (3): 949-54
- Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol. 1985; (2): 286-91
- Norwalk gastroenteritis: a community outbreak associated with bakery product consumption. Ann Intern Med. 1984; (4): 519-21
- Serological responses among teenagers after natural exposure to Norwalk virus. J Infect Dis. 1984; (4): 531-4
- Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis. 1984; (5): 694-702
- Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res. 1984; (2): 133-52
- Development of vaccines against rotavirus disease. Prog Food Nutr Sci. 1983; (3-4): 189-92
- Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol. 1983; (2): 310-7
- Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol. 1983: 313-20
- Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology. 1983; (1): 194-205
- Isolation and characterization of an equine rotavirus. J Clin Microbiol. 1983; (3): 585-91
- Isolation, propagation, and characterization of a second equine rotavirus serotype. Infect Immun. 1983; (3): 1031-7
- Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis. 1983; (1): 95-106
- Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol. 1983; (2): 267-75
- Serological comparison of canine rotavirus with various simian and human rotaviruses by plaque reduction neutralization and hemagglutination inhibition tests. Infect Immun. 1983; (1): 169-73
- Studies in volunteers with human rotaviruses. Dev Biol Stand. 1983: 209-18
- Norwalk gastroenteritis associated with a water system in a rural Georgia community. Arch Environ Health. 1982 Nov-Dec; (6): 358-60
- Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatment. Hepatology. 1982 Jan-Feb; (1): 39-49
- Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J Infect Dis. 1982; (4): 483-9
- Acute viral enteritis and exacerbations of inflammatory bowel disease. Gastroenterology. 1982; (6): 1207-9
- An outbreak of Norwalk gastroenteritis associated with swimming in a pool and secondary person-to-person transmission. Am J Epidemiol. 1982; (5): 834-9
- Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun. 1982; (1): 110-5
- Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med. 1982; (6 Pt 1): 756-61
- In vitro transcription of two human rotaviruses. J Virol. 1982; (3): 1032-7
- Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol. 1982; (2): 163-72
- Norwalk virus enteric illness acquired by swimming exposure. Am J Epidemiol. 1982; (2): 173-7
- Norwalk virus gastroenteritis following raw oyster consumption. Am J Epidemiol. 1982; (3): 348-51
- Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun. 1982; (1): 104-9
- Use of transcription probes for genotyping rotavirus reassortants. Virology. 1982; (2): 288-95
- Waterborne gastroenteritis due to the Norwalk agent: clinical and epidemiologic investigation. Am J Public Health. 1982; (1): 72-4
- Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. Hepatology. 1981 May-Jun; (3): 228-32
- Hepatitis B viral markers in severe viral hepatitis: influence of steroid therapy. Hepatology. 1981 Jan-Feb; (1): 54-7
- Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun. 1981; (2): 415-25
- Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun. 1981; (3): 958-61
- Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology. 1981; (2): 385-90
- Hazel elephant is dead (of tuberculosis) Am Rev Respir Dis. 1981; (3): 341
- Norwalk virus gastroenteritis in volunteers consuming depurated oysters. Aust J Exp Biol Med Sci. 1981; (Pt 2): 219-28
- Norwalk-related viral gastroenteritis due to contaminated drinking water. Am J Epidemiol. 1981; (4): 584-92
- Proteins of Norwalk virus. J Virol. 1981; (3): 994-9
- Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A. 1981; (1): 420-4
- Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis. 1980 May-Jun; (3): 459-69
- Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology. 1980; (6): 1495-9
- Detection of Escherichia coli enterotoxins in stools. Infect Immun. 1980; (1): 108-13
- Human rotavirus type 2: cultivation in vitro. Science. 1980; (4427): 189-91
- Infectious disease patterns in the Waorani, an isolated Amerindian population. Am J Trop Med Hyg. 1980; (2): 298-312
- Norwalk virus gastroenteritis aboard a cruise ship: an outbreak on five consecutive cruises. Am J Epidemiol. 1980; (6): 820-7
- Oyster-associated gastroenteritis in Australia: the detection of Norwalk virus and its antibody by immune electron microscopy and radioimmunoassay. J Med Virol. 1980; (1): 11-9
- Sampling New Orleans' drug addicts for tuberculosis. J La State Med Soc. 1980; (2): 17-8
- Antibodies to viral gastroenteritis viruses in Crohn's disease. Gastroenterology. 1979; (2): 349-50
- Diarrhea associated with rotavirus in rural Guatemala: a longitudinal study of 24 infants and young children. Am J Trop Med Hyg. 1979; (2): 325-8
- Enhancement of antigen incorporation and infectivity of cell cultures by human rotavirus. J Clin Microbiol. 1979; (4): 488-92
- Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol. 1979; (6): 903-9
- Mycoplasma contamination in cell culture of Crohn's disease material. Lancet. 1979; (8140): 466-7
- Norwalk virus in vomitus. Lancet. 1979; (8106): 55
- Prevalence of antibody to the Norwalk virus in various countries. Infect Immun. 1979; (1): 270-3
- Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology. 1979; (6): 1368-73
- Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis. 1979; (5): 564-8
- Solid-phase microtiter radioimmunoassay blocking test for detection of antibodies to Escherichia coli heat-labile enterotoxin. J Clin Microbiol. 1979; (1): 60-4
- Vomitus new nosocomial infection risk? No standard guidelines for isolation precautions. Hosp Infect Control. 1979; (3): 29-30
- Detection of Norwalk agent antibody and antigen by solid-phase radioimmunoassay and immune adherence hemagglutination assay. J Am Vet Med Assoc. 1978; (5 Pt 2): 620-3
- Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med. 1978; (21): 1156-61
- Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis. J Med Virol. 1978; (2): 89-96
- Prevalence of antibody to the Norwalk agent by a newly developed immune adherence hemagglutination assay. J Med Virol. 1978; (4): 281-94
- Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol. 1978; (2): 97-108
- Spontaneous resolution of severe aplastic anemia associated with viral hepatitis A in a 6-year-old child. Am J Hematol. 1978; (3): 247-52
- Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol. 1977; (5): 439-44
- Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun. 1977; (3): 541-5
- Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol. 1977; (2): 368-76
- Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976; (10): 517-22
- Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun. 1973; (4): 612-20
- An analysis of antibody response to Australia antigen in man. J Infect Dis. 1971; (4): 356-64
- Correlation of Australia antigen with posttransfusion hepatitis. JAMA. 1970; (5): 877-9
- Hepatitis antigen. Detection of infectious blood donors. Lancet. 1969; (7614): 248-9
Help
Trial Administration